DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS






Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient





 Company News
The Medicines Company (MDCO) To Buy Tenaxis Medical, Inc. In $170 Million Deal 4/23/2014 6:43:03 AM    More...
The Medicines Company (MDCO) To Announce First Quarter 2014 Financial Results On Wednesday, April 23, 2014 4/10/2014 10:24:30 AM    More...
FDA Accepts The Filing Of The Medicines Company (MDCO)'s US Biologic License Application For Fibrocaps Hemostatic Agent 4/4/2014 9:59:19 AM    More...
The Medicines Company (MDCO) Release: Update On Angiomax® (Bivalirudin) Patent Litigation 4/1/2014 11:01:28 AM    More...
Analysis Of EUROMAX And HORIZONS-AMI Trials Of The Medicines Company (MDCO)'s Angiomax(R) (Bivalirudin) Presented At American College of Cardiology14 3/31/2014 8:53:35 AM    More...
The Medicines Company (MDCO) To Participate In 2014 Barclays Global Healthcare Conference 3/7/2014 9:40:28 AM    More...
European Medicines Agency Accepts Marketing Authorization Application For The Medicines Company (MDCO)'s Oritavancin 2/27/2014 9:52:42 AM    More...
The Medicines Company (MDCO) Reports Fourth Quarter And Full Year 2013 Financial Results 2/20/2014 10:01:38 AM    More...
The Medicines Company (MDCO) To Participate In Upcoming Healthcare Investor Conferences 2/20/2014 9:29:30 AM    More...
FDA Accepts Filing Of The Medicines Company (MDCO)'s New Drug Application For Intravenous Antibiotic Oritavancin With Priority Review 2/19/2014 10:50:48 AM    More...
12345678910...